USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Marketplace Community ScreenersEfficient FrontierCorrelationsRisk/Return

US Market Open: Feb 9, 15:45 PM 2012

NYSE 8085.66 2.68 Index Moved Up

NASDAQ 2926.28 10.42 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for ALKS and ELN...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Alkermes Inc. and

Elan Corp. plc ADR

Volatility

Matrix

Run Correlation

Diversification

Modest diversification

Overlapping area represents amount of risk that can be diversified away by holding Alkermes Inc. and Elan Corp. plc ADR in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

0.22

Parameters

Time Period	1 Month [change]
Direction	Positive
Strength	Very Weak
Accuracy	95.83%
Values	Daily Returns

Suggest

Alkermes Inc.

Profile

18.54

Intraday

One Month

^(0.34)

1.80%

ALKS

NASDAQ

Alkermes Inc.

Day Low	18.46	Open	19.04
P/B Ratio	2.71	Market Cap	2.405B
Volume	435308	Sector	Healthcare
Last Close	18.88	Founded	Yes
Short Ratio	7.60	Last Traded	2/9/2012
Year High	20.00	Percent Change	1.80%
EBITDA	12.2M	Year Low	11.86
Absolute Change	0.34	Time	Not Applicable
Book Value	6.974	EPS	-0.60
PEG Ratio	0.13	Employees	600
Day High	19.05	Industry	Drug Delivery
Target Price	21.90	Current EPS	-0.60
This Year EPS	-0.62	Next Year EPS	-0.28

Elan Corporation plc ADR

Profile

13.09

Intraday

One Month

^(0.35)

2.60%

ELN

NYSE

Elan Corporation plc ADR

P/E	12.34	Day Low	13.00
Open	13.40	P/B Ratio	8.39
Market Cap	7.700B	Volume	3573414
Sector	Healthcare	Last Close	13.44
Short Ratio	2.20	Last Traded	2/9/2012
Year High	14.40	Percent Change	2.60%
EBITDA	196.2M	Year Low	6.10
Absolute Change	0.35	Time	Not Applicable
Book Value	1.602	EPS	1.089
Employees	1,219	Day High	13.61
Target Price	14.25	Current EPS	1.089
This Year EPS	1.14	Next Year EPS	0.10
Current PE	12.34	This Year PE	11.79
Next Year PE	134.40	Dividend	Not Applicable